Mariner
CTSO icon

Mariner’s Cytosorbents Corp CTSO Stock Holding History

Mariner’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-15,515
Closed -$103K – 757
2019
Q2 		$103K Buy
15,515
+245
+2% +$1.68K ﹤0.01% 1081
2019
Q1 		$116K Hold
15,270
– – ﹤0.01% 994
2018
Q4 		$123K Hold
15,270
– – ﹤0.01% 800
2018
Q3 		$197K Buy
+15,270
New +$191K 0.01% 774

Other funds holding CTSO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return

Mariner's CTSO Position: Q3 2019 in Review

Mariner sold out of Cytosorbents Corp (CTSO) in Q3 2019, closing a stake of 15,515 shares — an estimated $103K sold.

Mariner first reported a position in CTSO in Q3 2018 and held it in 4 quarters. The position peaked at $197K in Q3 2018. 69 funds tracked by Wall St. Rank hold CTSO as of Q3 2019.

  • Mariner reported no remaining Cytosorbents Corp position as of Q3 2019 after selling out during the quarter.
  • Mariner sold 15,515 Cytosorbents Corp shares in Q3 2019, an estimated $103K.
  • Mariner first reported a position in Cytosorbents Corp in Q3 2018 and held it in 4 quarters.
  • Mariner's Cytosorbents Corp position peaked at $197K in Q3 2018.
  • 69 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2019.

Based on Mariner's 13F filing for Q3 2019, filed 13 Nov 2019.